Waters Corporation has entered into a definitive merger agreement to acquire the outstanding capital stock of privately held Massachusetts-based NuGenesis Technologies Corporation for approximately $43 million, subject to the satisfaction of certain conditions contained in the merger agreement.
Bruker BioSciences Corporation announced that it is progressing rapidly with the implementation of its strategy to expand its global distribution and support capabilities.
STARLIMS Corporation announced an addition to the company's international coverage South Korea. The company's new partners are Interface Engineering Co. Ltd. (IEC), a long time player in the South Korean LIMS market.
PerkinElmer it has reached agreement with the U.S. Food and Drug Administration (FDA) whereby PerkinElmer will be permitted to resume production and shipment of newborn screening test kits at its Norton, Ohio facility.
InnaPhase announced the global release of Newton LIMS, a solution for pharmaceutical development, quality control, stability and environmental monitoring. The official release date of December 28, 2003 is in keeping with the Newton LIMS schedule unveiled at The 2003 Pittsburgh Conference.
L.I.M.S. (USA) Inc. has changed its name to STARLIMS Corporation, as part of its enhanced corporate identity strategy.
InnaPhase announced the addition of Robert Voelkner, formerly of Thermo Electron Corporation, as director of business development. In his new role, Voelkner will lead the effort to further expand InnaPhase's presence in various regions of the world.
InnaPhase announced the addition of Michael Tyszkiewicz, formerly of Applied Biosystems, as director of product development.
Tripos amended its strategic collaboration with Pfizer Inc. for the design, synthesis and purification of druglike compounds.
Agilent Technologies and Bayer Business Services (BBS) announced they will develop and market the
Tripos, Inc. and Chronogen Inc. announced a three-year collaboration to discover and optimize small-molecule therapeutics for cardiovascular disorders. Under the agreement, Tripos will employ its knowledge-driven chemistry process to provide complete drug discovery chemistry services for Chronogen.
Shimadzu Corporation announced a worldwide OEM distribution agreement with Nonlinear Dynamics, a provider of bioinformatics software solutions.
EMC Corporation announced a $40 million competitive award of EMC's networked storage, business continuity software and open management software for the Pentagon Renovation Office (PENREN), a large-scale initiative to modernize the Department of Defense's IT infrastructure.
The Food and Drug Administration (FDA) is amending its regulations to require electronic submission of labeling for review with new drug applications (NDAs), certain biological license applications (BLAs), abbreviated new drug applications (ANDAs), supplements, and annual reports.
Tim Berners-Lee, one of the the inventors of the World Wide Web and director of the World Wide Web Consortium (W3C), will be made a Knight Commander, Order of the British Empire (KBE) by Queen Elizabeth. This was announced by Buckingham Palace as part of the 2004 New Year's Honours list.